Skip to main content

CORRECTED-UPDATE 1-FDA approves Array BioPharma's melanoma combo treatment

June 27 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Wednesday it had approved Array BioPharma Inc's oral combination treatment for use in patients with the deadliest form of skin cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.